AI is transforming the life sciences industry by enhancing data integration, addressing ethical concerns, and ensuring secure, compliant AI applications across the pharma value chain.

AI can be a powerful enabler of cost efficiency and enhanced customer engagement, but only when aligned with broader business strategies and operational processes.

HCLTech offers a unique set of end-to-end AI capabilities, from chip development to business process optimization.

Agentic AI optimizes legacy cloud environments, automating maintenance and modernizing apps. HCLTech’s Google Cloud solutions cut infrastructure costs by 40% with intelligent agents and automation.

Intelligent GenAI infusion designed to streamline and optimize your ALM environment with scalability, modularity and ease of use​

Current DLP solutions enforce policies to prevent data breaches but may lack the adaptability to address new, sophisticated cyber threats

HCL Technologies DRYiCE™ announced the launch of DRYiCE IntelliOps (IntelliOps), a solution addressing the full-stack AIOps and observability needs of an enterprise.

AI that delivers ROI – Accelerate SAP & transform processes smartly

AI-empowered tools run by generative AI have opened new pathways to improving business processes and outcomes.

We acknowledge GenAl's transformative potential in cybersecurity and its profound impact on the industry.

AI and GenAI are transforming industries but pose regulatory and risk management challenges. This article explores AI governance to ensure ethical use of AI technologies.

GenAI plays a crucial role in not just enhancing productivity, it also empowers businesses to reimagine customer engagements, innovate new services and even pioneer novel business models.